Ministerial decision-making documents

Cabinet material: Transitioning of labelling requirements for medicines newly scheduled as controlled drugs under the Misuse of Drugs Act 1975

Proactive release of the Cabinet material relating to the transitioning of labelling requirements for medicines newly scheduled as controlled drugs under the Misuse of Drugs Act 1975

About us Mō mātou

Quick links

New Zealand’s health system

Organisation and leadership

Corporate publications

Careers

Regulation & legislation Ngā here me ngā ture

Quick links

Abortion

Assisted dying

Certification of health care services

Drug checking

Health Practitioners Competence Assurance Act

Medicinal cannabis

Medicines control

Mental health and addiction

Notifiable diseases

Pharmacy licensing

Psychoactive substances

Radiation

Smoked tobacco

Vaping, herbal smoking and smokeless tobacco

Strategies & initiatives He rautaki, he tūmahi hou

Health strategies

Programmes and initiatives

Māori health Hauora Māori

Quick links

Ao Mai te Rā anti-racism initiative

Māori health models

Te Tiriti o Waitangi framework

Wai 2575 Health Services and Outcomes Inquiry

Whakamaua: Māori Health Action Plan

Statistics & research He tatauranga, he rangahau

Quick links

System monitoring

Surveys

Statistics and data sets

Research

Cabinet material: Transitioning of labelling requirements for medicines newly scheduled as controlled drugs under the Misuse of Drugs Act 1975

Cabinet material: Transitioning of labelling requirements for medicines newly scheduled as controlled drugs under the Misuse of Drugs Act 1975

Downloads